エピソード

  • The Future of Weight Loss Drugs: Survodutide & Retatrutide. Ozempic & Mounjaro are only the beginning.
    2026/06/13

    In this #DoctorPodcasts Episode 149, we sit down with physician, Professor Carel le Roux, a global authority in metabolic medicine, #obesity and #diabetes to discuss the revolutionary shift in anti-obesity medications. We break down the differences between current leading GLP-1 drugs like #Ozempic (semaglutide) and #Mounjaro (tirzepatide), and look ahead to next-generation treatments. Dr. le Roux shares exclusive insights into the Phase 3 data for #Survodutide (Boehringer Ingelheim’s dual GLP-1/glucagon agonist), including its groundbreaking impact on visceral fat and #FattyLiverDisease (MASLD/MASH) via the SYNCHRONIZE trials. We also explore Eli Lilly’s upcoming triple agonist, Retatrutide. If you want to understand the future of weight loss, #MetabolicHealth, and how these drugs target the brain-gut axis, this deep dive is for you.0:00 - Introduction & Guest Overview0:34 - Episode Welcome: Dr. Robert Cykiert0:48 - Entering Dublin: The GLP-1 Breakthrough2:27 - Long-Term Health Hazards of Obesity & Diabetes3:24 - Why Obesity is a Disease of the Brain, Not Willpower4:57 - Ozempic (Semaglutide) vs. Mounjaro (Tirzepatide)6:16 - The Fatty Liver Disease (MASLD/MASH) Epidemic7:50 - The Truth About Visceral vs. Ectopic Fat10:04 - Survodutide Explained: The New Dual Agonist12:45 - Managing Side Effects & Titration Schedules15:37 - Boehringer Ingelheim & the Future of Obesity Medicine16:48 - Retatrutide: Eli Lilly’s New Triple Agonist18:26 - A 30-Second Guide for Doctors & Patients20:11 - Closing Thoughts & Patient Transformations

    続きを読む 一部表示
    21 分
  • Excellent Vision Without Glasses After Cataract Surgery: New Johnson & Johnson TECNIS PureSee IOL.
    2026/05/31

    Cataract surgery just entered a golden age with the recent historic FDA approval of the Johnson & Johnson (J&J) TECNIS PureSee IOL (intraocular lens). In Episode 146 of the @DoctorPodcasts Show, host Dr. Robert Cykiert speaks with world-renowned cataract surgeon, Dr. Eric Donnenfeld, and J&J Vision Senior Medical Director and ophthalmologist, Dr. Brian Schwam, to break down this major milestone. If you or a loved one suffer from blurry vision, halos and glare due to cataracts, standard monofocal IOL lenses often lock you into wearing reading glasses all the time. The J&J Tecnis PureSee represents a massive premium IOL leap forward—using a purely refractive design rather than older diffractive rings. This allows patients to maintain maximum contrast sensitivity and crisp vision across all distances - distance, intermediate and near - without losing light intensity, contrast and brightness. Discover why 97% of PureSee patients recommend this treatment and whether you are a prime candidate for this IOL lens. Subscribe to The DoctorPodcasts Show for frequent medical expert insights!

    #Cataract

    #Tecnis

    #EyeHealth

    #Ophthalmology

    #DoctorPodcasts

    #PureSee


    Important Safety Information: https://jjvision.com/en-us/safety-information/?tab=4


    0:00 - Introducing the J&J Tecnis PureSee Lens Breakthrough 0:21 - Welcome to The Doctor Podcast Show Ep. 146

    1:03 - Meet Expert Pioneers Dr. Donnenfeld & Dr. Schwam 3:16 - What is a Cataract and Why Do We Get Them?

    4:23 - Main Symptoms: Blurry Vision, Glare, and Halos

    5:21 - Standard Monofocal Lenses vs. Premium Options

    8:52 - How Multifocal and Extended Depth of Focus (EDOF) Work 10:09 - The Biggest Trade-offs of Older Eye Implants

    11:55 - Rigorous FDA Clinical Trials Criteria Explained

    15:21 - Refractive vs. Diffractive Design: Stopping Light Splitting 17:41 - Over 500,000 Safe International Implantations

    22:26 - Real-World Evidence & High Patient Satisfaction

    23:24 - Who is a Good Candidate for the PureSee Lens?

    25:36 - 25 Years of Innovation at J&J Vision 27:32 - Final Expert Advice: Choosing the Right Ophthalmologist 29:10 - The Future of Eye Care: AI and Robotic Cataract Surgery

    続きを読む 一部表示
    32 分
  • Revolutionizing Medical Education to Prepare Future-Ready Physicians in the AI Age
    2026/05/22

    DoctorPodcasts video podcast EPISODE 148:Watch David L. Battinelli M.D, , Dean of the Zucker School of Medicine and Physician-in-Chief of Northwell Health in Long Island, NY, co-author of a new book, Revolutionizing Medical Education: A Proven Blueprint to Transform Curricula and Prepare Future-Ready Physicians, discuss how to change traditional medical school curricula to prepare physicians for modern medicine in the AI age. Book information at: https://www.wiley.com/en-us/Revolutionizing+Medical+Education%3A+A+Proven+Blueprint+to+Transform+Curricula+and+Prepare+Future-Ready+Physicians-p-9781394416042 Dr. Battinelli information at: https://faculty.medicine.hofstra.edu/1484-david-battinelli#DoctroPodcasts is the leading physician-hosted video podcast that informs, inspires and builds trust in healthcare and medicine. Watch all 148 episodes of the DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes https://www.doctorpodcasts.com/index-of-doctorpodcasts-episodes/.Send questions, comments, suggestions, reviews and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.#AIinMedicine

    #MedicalEducation

    #FutureOfMedicine

    #MedEd

    #HealthcareAI

    #DoctorPodcast

    #MedicalSchool

    #RevolutionizingMedEd

    #HealthTech

    #AIMedicalEducation

    #PhysicianLeadership

    #DigitalHealth

    #MedStudentLife

    #PodcastForDoctors

    #AIinHealthcare

    #DoctorPodcasts

    #FutureDoctors

    #MedicalInnovation

    #CykiertFiles

    #healthcareleadership #hofstra #northwell

    #battinelli

    続きを読む 一部表示
    33 分
  • Hantavirus, cruise ships and rats. What you must know.
    2026/05/20

    Deadly #Hantavirus just killed 3 people on a cruise ship. It’s the rare strain that spreads between humans. Top Hantavirus expert Dr. Steven Bradfute breaks down the virus details, prevention, symptoms, treatment, & what you need to know about rats and cruise ships.


    Watch all 147 episodes of the #DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts https://www.doctorpodcasts.com/index-of-doctorpodcasts-episodes/. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments, suggestions, reviews and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.


    #Hantavirus

    #HantavirusOutbreak

    #CruiseShipHantavirus

    #AndesVirus

    #HantavirusPulmonarySyndrome

    #RodentBorneVirus

    #DeadlyCruiseShipVirus


    #HantavirusPrevention


    #DrStevenBradfute

    #DoctorPodcasts

    #HealthPodcast

    #ViralOutbreak2026

    #CruiseShipSafety

    #RatVirusAlert

    #EmergingInfectiousDisease

    #robertcykiert

    #robertcykiertmd

    #virus #rats

    #rodents

    続きを読む 一部表示
    38 分
  • Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease.
    2026/05/11

    Got dry mouth, dry eyes, joint pains, chronic fatigue? Get checked for often-undiagnosed Sjögren’s Disease. Watch this video podcast with rheumatologist & Sjogren's expert, Sara McCoy, M.D. discussing Novartis #ianalumab FDA Breakthrough Therapy Designation. More information is available at: https://www.novartis.com/news/media-releases/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-diseaseandhttps://sjogrens.org/andhttps://www.uwhealth.org/providers/sara-s-mccoy-mdandhttps://www.novartis.com/us-en/patients-and-caregiversWatch all 145 episodes of the #DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts http://Doctorpodcasts.com/index-of-doctoof-doctoof-doctoof-doctorpodcasts-episodes. Please SUBSCRIBE & FOLLOW @DoctorPodcasts . Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments, suggestions, reviews and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.#Sjogrens

    #SjogrensSyndrome

    #SjogrensDisease

    #Autoimmune

    #AutoimmuneDisease

    #Rheumatology

    #DryEyesDryMouth

    #ChronicFatigue

    #InvisibleIllness

    #ChronicIllness

    #RareDiseaseAwareness

    #BreakthroughTherapy

    #PatientEducation

    #MedicalPodcast

    #HealthPodcast

    #WomenAndAutoimmunity

    #LivingWithSjogrens

    #RheumLife

    続きを読む 一部表示
    45 分
  • Want to ditch your reading glasses & bifocals?
    2026/04/29

    New, FDA-approved YUVEZZI eye drops made by Tenpoint Therapeutics, are changing how we treat age-related presbyopia, or difficulty with close-up reading vision. Two top eye doctors reveal how this unique 2-ingredient eye drop gives you sharp near and reading vision, without surgery. Watch DoctorPodcasts Episode 144 for more information. Check out https://www.yuvezzi.com and https://tenpointtherapeutics.com for details.

    #DoctorPodcasts

    #YUVEZZI

    #presbyopia #readingglassespodcast #glasses #YUVEZZIEyeDrops

    #DitchReadingGlasses

    #NoMoreBifocals

    #PresbyopiaTreatment

    #FDAApprovedEyeDrops

    #VisionWithoutSurgery

    #CykiertFiles

    #RobertCykiertMD

    #EyeHealth

    #Ophthalmology

    #NonSurgicalVision

    #medicalinnovation #doctorpodcasts #blurry

    #bifocals

    #contactlenses #carbachol

    #brimonidine

    #optometrist

    #ophthalmologist


    続きを読む 一部表示
    30 分
  • Hypertrophic obstructive CardioMyopathy (HCM), a leading cause of sudden death in young fit athletes
    2026/04/25

    DoctorPodcasts EPISODE 143:Young, fit, college and professional athletes🏃‍♀️🏀🏈 sometimes collapse and suddenly die during competition due to silent Hypertrophic obstructive CardioMyopathy (HCM) heart disease. Watch cardiologist Martin S. Maron, M.D. https://physicians.lahey.org/details/4568 discuss how Cytokinetics https://cytokinetics.com biopharmaceutical company's new FDA-approved drug, MYQORZO, https://www.myqorzo.com treats this condition.Watch all 143 episodes of the DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts at https://www.doctorpodcasts.com/index-of-doctorpodcasts-episodes. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments, suggestions, reviews and messages to DoctorPodcasts. Thank you. Robert Cykiert, M.D.#Myqorzo

    #Aficamten

    #HCM

    #HypertrophicCardiomyopathy

    #Cardiology

    #SportsCardiology

    #DoctorPodcasts

    #MedicalPodcast

    #SuddenCardiacDeath

    #AthleteSafety

    #FDAapproved

    #HCMAwareness

    #RobertCykiert

    #RobertCykiertMD

    続きを読む 一部表示
    35 分
  • Ataxia: The rare neurodegenerative disease with decades-long difficulty getting approved treatments.
    2026/04/23

    DoctorPodcasts Episode 142:Watch http://Ataxia.org CEO, Andrew Rosen discuss patient & family support, research progress, regulatory hurdles and real world evidence for new clinical trials.Watch all 142 episodes of the DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments, suggestions, reviews and messages to DoctorPodcasts. Thank you. Robert Cykiert, M.D.#AtaxiaAwareness
    #RareDisease
    #Ataxia
    #RareDiseaseAwareness
    #Neurology
    #DoctorPodcasts
    #MedicalPodcast
    #PatientAdvocacy
    #NeuroTwitter
    #AcceleratingCures
    #RareDiseases
    #PodcastVideo
    #HealthPodcast
    #NeurologicalDisorders
    #CykiertFiles

    続きを読む 一部表示
    25 分